Second Opinion September 26, 2024
Health care is a tough market, but there are invariably going to be big opportunities, according to Maveron’s Jason Stoffer
This post is written by Jason Stoffer, an investor with Maveron, and the latest in our new guest authors series.
I’m not a dedicated digital health investor. But I will occasionally invest in the area, particularly when there’s an opportunity that aligns with patients and consumers. So consider this analysis as the perspective of an outsider with an insider’s seat from time to time. It gives me an opportunity to take a birds’ eye view, but also to be as objective as possible.
After a wild roller coaster ride of digital health funding...